Anti-SARS-CoV-2 receptor binding domain antibodies after the second dose of Sinovac and AstraZeneca vaccination

PURPOSE: The Sinovac and AstraZeneca vaccines are the primary coronavirus disease 2019 vaccines in Indonesia. Antibody levels in vaccine-injected individuals will decline substantially over time, but data supporting the duration of such responses are limited. Therefore, this study aims to quantitati...

Descripción completa

Detalles Bibliográficos
Autores principales: Gondokesumo, Marisca Evalina, Purnamayanti, Anita, Hanum, Puri Safitri, Santosa, Winnie Nirmala, Wardhana, Ardyan Prima, Avanti, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435773/
https://www.ncbi.nlm.nih.gov/pubmed/37599805
http://dx.doi.org/10.7774/cevr.2023.12.3.224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435773/
https://www.ncbi.nlm.nih.gov/pubmed/37599805
http://dx.doi.org/10.7774/cevr.2023.12.3.224

Ejemplares similares